ETFs Similar to HRTS
Comparison Results
| Name | Price | Price Change | Price Target | Smart Score | Expense Ratio | Asset Under Management | Follow |
|---|---|---|---|---|---|---|---|
| PBPHPortfolio Building Block World Pharma and Biotech Index ETF | $31.35 | $33.15(5.75% Upside) | 0.13% | 1.17B | |||
| CANCTema Oncology ETF | $42.29 | $60.70(43.54% Upside) | 0.75% | 216.18M | |||
| LFSCF/M Emerald Life Sciences Innovation ETF | $43.60 | $66.89(53.44% Upside) | 0.54% | 125.43M | |||
| IBBQInvesco Nasdaq Biotechnology ETF | $36.17 | $45.67(26.27% Upside) | 0.19% | 120.43M | |||
| OZEMRoundhill GLP-1 & Weight Loss ETF | $30.70 | $48.00(56.37% Upside) | 0.59% | 55.57M | |||
| PSILAdvisorShares Psychedelics ETF | $21.00 | $55.10(162.38% Upside) | 1.00% | 46.62M | |||
| IBRNiShares Neuroscience and Healthcare ETF | $32.84 | $55.35(68.57% Upside) | 0.47% | 6.66M | |||
| THNRAmplify Weight Loss Drug & Treatment ETF | $25.95 | $35.58(37.13% Upside) | 0.59% | 5.83M | |||
| PEPTREX Peptide ETF | $27.01 | $37.55(39.02% Upside) | 0.65% | 1.88M | |||
| BIBProShares Ultra Nasdaq Biotechnology | $120.53 | ― | 0.95% | 103.75M |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 31.35 | 6.30 | 25.14% | |
| CANC | Tema Oncology ETF | 42.29 | 11.65 | 38.04% | |
| LFSC | F/M Emerald Life Sciences Innovation ETF | 43.60 | 11.31 | 35.02% | |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 36.17 | 10.11 | 38.81% | |
| OZEM | Roundhill GLP-1 & Weight Loss ETF | 30.70 | 2.02 | 7.03% | |
| PSIL | AdvisorShares Psychedelics ETF | 21.00 | 3.77 | 21.91% | |
| IBRN | iShares Neuroscience and Healthcare ETF | 32.84 | 3.52 | 12.00% | |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 25.95 | 3.09 | 13.52% | |
| PEPT | REX Peptide ETF | 27.01 | 1.95 | 7.79% | |
| BIB | ProShares Ultra Nasdaq Biotechnology | 120.53 | 51.05 | 73.47% |
ETFs Similar to HRTS FAQ
What is the cheapest alternative to HRTS?
Among the ETFs similar to HRTS, PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) has the lowest expense ratio, at 0.13% a year, compared with 0.75% for HRTS.
HRTS vs. PBPH: what is the difference?
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) is the first ETF in HRTS's similar-ETF list. It has $1.17B in assets under management and a 0.13% expense ratio, against $57.10M and 0.75% for HRTS. Compare their performance, price targets and Smart Scores in the table above.
How is HRTS different from CANC?
CANC (Tema Oncology ETF) comes from the same fund family as HRTS (Tema). CANC charges 0.75% a year, against 0.75% for HRTS. CANC manages $216.18M in assets, against $57.10M for HRTS. Both funds are in the comparison table above.
